Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways

Figure 3

PIO protects against cardiac hypertrophy by inhibition of MAPK and AKT/GSK3β pathways. Representative and quantitative expression of PPARγ, phosphorylated AKT, GSK3β, ERK, P38, and the effects of PIO in group of AB or sham with or without PIO (). .